Heterozygous Deletion in Exons 4-5 of SHOX Gene in a Patient Diagnosed as Idiopathic Short Stature

1. Montalbano A, Juergensen L, Roeth R et al. - Retinoic acid catabolizing enzyme CYP26C1 is a genetic modifier in SHOX deficiency. EMBO Mol Med. 2016;8:1455-1469.10.15252/emmm.201606623516713527861128Search in Google Scholar

2. Marchini A, Ogata T, Rappold GA - A Track Record on SHOX: From Basic Research to Complex Models and Therapy. Endocr Rev. 2016;37:417-448.10.1210/er.2016-1036497131027355317Search in Google Scholar

3. Bertalan R, Halász Z - A SHOX gén vizsgálatának klinikai jelentősége alacsonynövésben. Magy Belorv Arch. 2011;64:284-288.Search in Google Scholar

4. Alvarez-Mora MI, Madrigal I, Rodriguez-Revenga L et al. - A 170P mutation in SHOX gene in a patient not presenting with Madelung deformity. J Clin Pathol. 2012;65:844-846.10.1136/jclinpath-2011-20062622461651Search in Google Scholar

5. Valetto A, Bertini V, Michelucci A et al. - Short Stature in Isodicentric Y Chromosome and Three Copies of SHOX Gene: Clinical report and Review of Literature. Mol Syndromol. 2016;7:19-25.10.1159/000444430486239327194969Search in Google Scholar

6. Choi WB, Seo SH, Yoo WH, Kim SY, Kwak MJ - A Leri-Weill dyschondrosteosis patient confirmed by mutation analysis of SHOX gene. Ann Pediatr Endocrinol Metab. 2015;20:162-165.10.6065/apem.2015.20.3.162462334526512353Search in Google Scholar

7. Donze SH, Meijer CR, Kant SG et al. - The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects. Eur J Endocrinol. 2015;173:611-621.10.1530/EJE-15-045126264720Search in Google Scholar

8. Albuisson J, Schmitt S, Baron S, Bezieau S, Benito-Sanz S, Heath KE - Clinical utility gene card for: Leri-Weill dyschondrosteosis (LWD) and Langer mesomelic dysplasia (LMD). Eur J Hum Genet 2012; 20(8). doi:10.1038/ejhg.2012.6410.1038/ejhg.2012.64340073922510850Search in Google Scholar

9. Binder G - Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm Res Paediatr. 2011;75:81-89.10.1159/00032410521325865Search in Google Scholar

10. Rappold G, Blum WF, Shavrikova EP et al. - Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet. 2007;44:306-313.10.1136/jmg.2006.046581259798017182655Search in Google Scholar

11. Blum WF, Crowe BJ, Quigley CA et al. - SHOX Study Group: Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007;92:219-228.10.1210/jc.2006-140917047016Open DOISearch in Google Scholar

12. Ross JL, Kowal K, Quigley CA et al.- The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. J Pediatr. 2005;147:499-507.10.1016/j.jpeds.2005.04.06916227037Search in Google Scholar

13. Binder G, Rappold GA - SHOX deficiency disorders. In: Pagon RA, Adam MP, Ardinger HH et al, editors. GeneReviews [Internet]. Seattle, WA: University of Washington 2005. Available at https://www.ncbi.nlm.nih.gov/pubmed/20301394.Search in Google Scholar

14. Miclea DL, Al Khzouz C, Bucerzan S et al. - Assessment of the SHOX gene and chromosomal abnormalities by molecular and classical cytogenetics in patients with short stature. Acta Endo. 2015;11:463-469.10.4183/aeb.2015.463Search in Google Scholar

15. Funari MF, Jorge AA, Souza SC et al. - Usefulness of MLPA in the detection of SHOX deletions. Eur J Med Genet. 2010;53:234-238.10.1016/j.ejmg.2010.06.00120538086Search in Google Scholar